1. Abbot, A., Interrelationship between Na− and Ca2+ Metabolism in hypertension.TIPS. 9, 111–113 (1988).
2. Bondy, S. C. and Konulainen, H. Increased free intracellular Ca2+ by toxic agents: an index of potential neurotoxicity.TIPS, 9, 154–156 (1988).
3. Fleckenstein, A. Calcium antagonism: History and prospects for a multifaceted pharmacological principle. In: Calcium antagonists and cardiovascular disease. L. H. Opie (Ed.). Raven press. New York, 9–28 (1984).
4. Floyd, D. M., Kimball, S. D., Krapcho, J., Das, J., Turk, C. F., Moquin, R. B., Lago, M. W., Duff, K. J., Lee, V. G., White, R. E., Ridgewell, R. E., Moreland, S., Brittain, R. J., Normandin, D. E., Hedberg, S. A. and Cucinotta, G. G., Benzazepinone calcium channel blockers. 2. Structure-activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones.J. Med. Chem., 35, 756–772 (1992).
5. Inoue, H., Hashiyama, T., Takeda, M., Aoe, K. and Kotera, K., Reaction of 3-phenylglycidic esters. Part 2. Stereo- and Regio-selectivity in the oxirane ring opening of methyltrans-3-(4-mehtoxyphebyl)glycidate with various thiophenols and the effects of solvent and temperature.J. Chem. Soc. Perkin Trans. I., 421–426 (1985).